Ardelyx (ARDX)
(Delayed Data from NSDQ)
$6.48 USD
-0.01 (-0.08%)
Updated Apr 22, 2024 11:56 AM ET
3-Hold of 5 3
F Value B Growth F Momentum D VGM
Brokerage Reports
0 items in cart
Ardelyx, Inc. [ARDX]
Reports for Purchase
Showing records 1 - 20 ( 166 total )
Company: Ardelyx, Inc.
Industry: Medical - Drugs
It''s Just A Bill, Sitting On Capitol Hill. But, Kidney PATIENT Act Marked Up
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Company: Ardelyx, Inc.
Industry: Medical - Drugs
4Q Recap; IBSRELA Begins March to $1B U.S. Net Sales By 2033
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Biotechnology- Survey Says... Latest Nephrology Survey Sheds Light On Prescribing Trends
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Ibsrela Continues to Perform, As Xphozah Starting to Move; 4Q23 Preannouncement
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
ScriptWatch 2023: Ibsrela, Xphozah Prescription Trends
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
ScriptWatch 2023: Ibsrela, Xphozah Prescription Trends
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Company: Ardelyx, Inc.
Industry: Medical - Drugs
ScriptWatch 2023: Ibsrela, Xphozah Prescription Trends
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
ScriptWatch 2023: Ibsrela, Xphozah Prescription Trends
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
XPHOZAH Shipments to U.S. Pharmacies Underway to Provide Unique Alternative to Phosphate Binders
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E
Company: Ardelyx, Inc.
Industry: Medical - Drugs
The IgAN Era Continues, While Xphozah Makes A Splash Ahead Of Launch
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Biotechnology-The Wedbush Monthly Check-Up: November 2023
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
3Q Recap; Ardelyx Firing On All Cylinders; Increasing PT to Reflect Higher Than Expected XPHOZAH Pricing; Affirm Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Get Your Commercial Engines Started -- Xphozah Prepares To Launch
Provider: Wedbush Securities Inc.
Analyst: CHICO L